SCHEMBL2533717

SCHEMBL2533717

CCOC(=O)c1ccc2c(c1)CC(C)(C)C(c1cccc(NC(C)(C)C(=O)NC)c1)N2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.38
NPC1 O15118 5/20 0.35
RAB9A P51151 5/20 0.35
KDM4E B2RXH2 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 6/20 0.34
POLB P06746 4/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
ALDH1A1 P00352 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
GAA P10253 2/20 0.34
THRB P10828 2/20 0.34
MASP2 O00187 1/20 0.34
GAPDH P04406 1/20 0.34
HSPA1A P0DMV8 1/20 0.34
HSPA8 P11142 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
NR4A1 P22736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2529423 0.93 AR (0.41) ARNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL2531417 0.91 AR (0.37) ARNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL2529386 0.91 AR (0.39) ARNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL2534388 0.89 AR (0.38) ARNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL2531594 0.88 AURKA (0.33) NPC1RAB9AKDM4EMAPTPOLB
SCHEMBL2536543 0.88 AR (0.42) ARNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL2535671 0.87 AR (0.36) ARKDM4EMAPTPOLBALDH1A1
SCHEMBL2535713 0.86 ALDH1A1 (0.41) ARRAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL2534177 0.84 AR (0.41) ARNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL2536331 0.84 KMT2A (0.44) ARNPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 AR 1900/4885NPC1 429/4885RAB9A 364/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 AR 1900/4885NPC1 429/4885RAB9A 364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.